"Obesity stigma is rising due to new weight-loss drugs" - Prof. Donal O'Shea
Brendan O'Connor
00:00
How will oral versions change accessibility and demand
Donal explains the impact of tablet GLP‑1s on uptake, global availability, WHO essential medicine status, and likely increased casual use.
Play episode from 07:30
Transcript
